{"organizations": [], "uuid": "b39241037fe6780217b3de117b14a3619d33dd46", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/29/pr-newswire-tapimmune-to-provide-fourth-quarter-and-full-year-2017-business-update-conference-call-and-webcast.html", "country": "US", "domain_rank": 767, "title": "TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-03-29T14:30:00.000+03:00", "replies_count": 0, "uuid": "b39241037fe6780217b3de117b14a3619d33dd46"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/29/pr-newswire-tapimmune-to-provide-fourth-quarter-and-full-year-2017-business-update-conference-call-and-webcast.html", "ord_in_thread": 0, "title": "TapImmune to Provide Fourth Quarter and Full Year 2017 Business Update Conference Call and Webcast", "locations": [], "entities": {"persons": [], "locations": [{"name": "webcast jacksonville", "sentiment": "none"}, {"name": "fla.", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "tapimmune inc.", "sentiment": "negative"}, {"name": "company", "sentiment": "none"}, {"name": "tapimmune inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "JACKSONVILLE, Fla., March 29, 2018 /PRNewswire/ -- TapImmune Inc. (NASDAQ: TPIV ), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that the Company will host a conference call and live audio webcast on Thursday, April 5, 2018, at 4:30 p.m. ET, to provide a corporate and clinical update for the fourth quarter and year end 2017.\nReserve Your Seat: Register Today\nThe event will be webcast live via the Internet on:\nApril 5, 2018\n4:30 PM ET\nClick here to register today, or visit https://tapimmune.com/register\nDay-of Call-in Information:\nTo access the live conference call on April 5, 2018, at 4:30pm ET you may use:\n(855) 238-2333 (U.S.) (412) 317-5215 (International)\nTo access the live audio webcast, visit the Events section of the TapImmune website: http://tapimmune.com/events . The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on April 5, 2018.\nAbout TapImmune Inc.\nTapImmune Inc. is a leader in the development of novel immunotherapies for cancer, with multiple Phase 2 and Phase 1b/2 clinical studies currently ongoing for the treatment of ovarian and breast cancer. The company's peptide or nucleic acid-based immunotherapeutic products comprise multiple naturally processed epitopes (NPEs) that are designed to comprehensively stimulate a patient's killer T-cells and helper T-cells, and to restore or further augment antigen presentation using proprietary nucleic acid-based expression systems. This unique approach can produce off-the-shelf T-cell vaccine candidates that elicit a broad-based T-cell response and can be used without respect to HLA type. The company's technologies may be used as stand-alone medications or in combination with other treatment modalities.\nFor additional information visit: https://tapimmune.com/\nTo receive future press releases via email, please visit:\nhttps://tapimmune.com/investors/email-alerts/\nFollow us on Twitter @Tapimmune_Inc , or follow us on Facebook .\nFor answers to frequently asked questions, please visit our FAQs page: https://tapimmune.com/investors/frequently-asked-questions/\nView original content with multimedia: http://www.prnewswire.com/news-releases/tapimmune-to-provide-fourth-quarter-and-full-year-2017-business-update-conference-call-and-webcast-300621358.html\nSOURCE TapImmune Inc.", "external_links": ["https://tapimmune.com/investors/frequently-asked-questions/", "https://www.facebook.com/tap.immune/", "https://tapimmune.com/investors/email-alerts/", "https://tapimmune.com/register", "https://twitter.com/tapimmune_inc", "http://www.prnewswire.com/news-releases/tapimmune-to-provide-fourth-quarter-and-full-year-2017-business-update-conference-call-and-webcast-300621358.html", "https://finance.yahoo.com/quote/tpiv?ltr=1", "https://tapimmune.com/", "https://www.webcaster4.com/Webcast/Page/1651/25223", "http://www.tapimmune.com/", "https://tapimmune.com/event/tapimmune-to-provide-fourth-quarter-and-full-year-2017-business-update-conference-call-and-webcast/", "http://tapimmune.com/events"], "published": "2018-03-29T14:30:00.000+03:00", "crawled": "2018-03-29T14:08:03.000+03:00", "highlightTitle": ""}